These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9178474)

  • 1. Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease.
    Yule TD; Roth MB; Dreier K; Johnson AF; Palmer-Densmore M; Simmons K; Fanton R
    Vaccine; 1997; 15(6-7):720-9. PubMed ID: 9178474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant?
    Larson LJ; Schultz RD
    Vet Ther; 2008; 9(2):94-101. PubMed ID: 18597247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
    Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
    Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
    Siedek EM; Schmidt H; Sture GH; Raue R
    Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus.
    Buonavoglia C; Cavalli A; Gravino E; Voigt V; Buonavoglia D; de Caprariis D
    Zentralbl Veterinarmed B; 1994 Mar; 41(1):3-8. PubMed ID: 7941844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroconversion of puppies to canine parvovirus and canine distemper virus: a comparison of two combination vaccines.
    Coyne MJ
    J Am Anim Hosp Assoc; 2000; 36(2):137-42. PubMed ID: 10730624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs.
    Freisl M; Speck S; Truyen U; Reese S; Proksch AL; Hartmann K
    Vet J; 2017 Jan; 219():15-21. PubMed ID: 28093104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ; Schultz RD
    Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody levels and protection to canine parvovirus type 2.
    Elia G; Cavalli A; Cirone F; Lorusso E; Camero M; Buonavoglia D; Tempesta M
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):320-2. PubMed ID: 16316392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b).
    Pratelli A; Cavalli A; Normanno G; De Palma MG; Pastorelli G; Martella V; Buonavoglia C
    J Vet Med B Infect Dis Vet Public Health; 2000 May; 47(4):273-6. PubMed ID: 10861195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of vaccination at 4 and 6 weeks in the control of canine parvovirus.
    De Cramer KG; Stylianides E; van Vuuren M
    Vet Microbiol; 2011 Apr; 149(1-2):126-32. PubMed ID: 21111542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early protection of puppies against canine parvovirus: a comparison of two vaccines.
    McCaw DL; Tate D; Dubovi EJ; Johnson JC
    J Am Anim Hosp Assoc; 1997; 33(3):244-50. PubMed ID: 9138235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c.
    Wilson S; Illambas J; Siedek E; Stirling C; Thomas A; Plevová E; Sture G; Salt J
    Vaccine; 2014 Sep; 32(42):5420-4. PubMed ID: 25148778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: A systematic review of controlled clinical trials.
    Hernández-Blanco B; Catala-López F
    Vet Microbiol; 2015 Oct; 180(1-2):1-9. PubMed ID: 26249827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
    Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oral Sindbis virus replicon-based DNA vaccine containing VP2 gene of canine parvovirus delivered by Escherichia coli elicits immune responses in dogs.
    Dahiya SS; Saini M; Kumar P; Gupta PK
    Acta Virol; 2011; 55(4):289-94. PubMed ID: 22149493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of modified live canine parvovirus type 2b induces systemic immune response.
    Cavalli A; Desario C; Marinaro M; Losurdo M; Camero M; Decaro N; Catella C; Lanave G; Buonavoglia C
    Vaccine; 2020 Jan; 38(2):115-118. PubMed ID: 31628031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine.
    Buonavoglia C; Tollis M; Buonavoglia D; Puccini A
    Comp Immunol Microbiol Infect Dis; 1992 Oct; 15(4):281-3. PubMed ID: 1330425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose.
    Buonavoglia C; Cavalli A; Tempesta M; Voight V; Buonavoglia D; Corrente M; Sagazio P
    New Microbiol; 1995 Oct; 18(4):371-5. PubMed ID: 8590389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the natural immunity in pups inoculated with a modified-live canine parvovirus type 2b (CPV-2b) strain.
    Pratelli A; Altamura M; Buonavoglia D; Pepe M; Tafaro A; Lembo A; Cirone F; Tempesta M; Jirillo E; Buonavoglia C
    Immunopharmacol Immunotoxicol; 2000 Aug; 22(3):451-64. PubMed ID: 10946825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.